Clinical trial
Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell…
NCT00324779 · University Hospital Erlangen, Other · Completed
Key facts
| NCT number | NCT00324779 |
|---|---|
| Title | Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia |
| Official title | Multicenter Therapy Study for Children With Mature B-NHL or B-ALL With a Rituximab - Window Before Chemotherapy |
| Lead sponsor | University Hospital Erlangen, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Biological |
| Interventions | rituximab |
| Enrollment | 79 |
| Start date | Mar 1, 2004 |
| Primary completion | Apr 1, 2011 |
| First posted | May 11, 2006 |
| Last update posted | Sep 25, 2015 |
| Countries | Germany, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: